Works by Shon, Ho Sang

Results: 17
    1
    2

    Combined use of basal insulin analog and acarbose reduces postprandial glucose in patients with uncontrolled type 2 diabetes.

    Published in:
    Journal of Diabetes Investigation, 2015, v. 6, n. 2, p. 219, doi. 10.1111/jdi.12261
    By:
    • Kim, Ji‐Hyun;
    • Ahn, Ji‐Hyun;
    • Kim, Soo‐Kyung;
    • Lee, Dae‐Ho;
    • Kim, Hye‐Soon;
    • Shon, Ho‐Sang;
    • Jeon, Hyun‐Jeong;
    • Kim, Tae‐Hwa;
    • Cho, Yong‐Wook;
    • Kim, Jae‐Taek;
    • Han, Sung‐Min;
    • Chung, Choon‐Hee;
    • Ryu, Ohk‐Hyun;
    • Lee, Jae‐Min;
    • Lee, Soon‐Hee;
    • Kwon, Min‐Jeong;
    • Kim, Tae‐kyun;
    • Namgoong, Il‐Seong;
    • Kim, Eun‐Sook;
    • Jung, In‐Kyung
    Publication type:
    Article
    3
    4
    5
    6
    7
    8

    Efficacy and Safety of Metformin and Atorvastatin Combination Therapy vs. Monotherapy with Either Drug in Type 2 Diabetes Mellitus and Dyslipidemia Patients (ATOMIC): Double-Blinded Randomized Controlled Trial.

    Published in:
    Diabetes & Metabolism Journal, 2024, v. 48, n. 4, p. 730, doi. 10.4093/dmj.2023.0077
    By:
    • Jie-Eun Lee;
    • Seung Hee Yu;
    • Sung Rae Kim;
    • Kyu Jeung Ahn;
    • Kee-Ho Song;
    • In-Kyu Lee;
    • Ho-Sang Shon;
    • In Joo Kim;
    • Soo Lim;
    • Doo-Man Kim;
    • Choon Hee Chung;
    • Won-Young Lee;
    • Soon Hee Lee;
    • Dong Joon Kim;
    • Sung-Rae Cho;
    • Chang Hee Jung;
    • Hyun Jeong Jeon;
    • Seung-Hwan Lee;
    • Keun-Young Park;
    • Sang Youl Rhee
    Publication type:
    Article
    9
    10
    11

    Efficacy and safety of a fixed‐dose combination of dapagliflozin and linagliptin (AJU‐A51) in patients with type 2 diabetes mellitus: A multicentre, randomized, double‐blind, parallel‐group, placebo‐controlled phase III study

    Published in:
    Diabetes, Obesity & Metabolism, 2025, v. 27, n. 1, p. 81, doi. 10.1111/dom.15985
    By:
    • Hong, Jun Hwa;
    • Kim, Myung Jin;
    • Min, Kyung Wan;
    • Won, Jong Chul;
    • Kim, Tae Nyun;
    • Lee, Byung‐Wan;
    • Kang, Jun Goo;
    • Kim, Jae Hyeon;
    • Park, Jung Hwan;
    • Ku, Bon Jeong;
    • Lee, Chang Beom;
    • Kim, Sang Yong;
    • Shon, Ho Sang;
    • Lee, Woo Je;
    • Park, Joong‐Yeol
    Publication type:
    Article
    12

    Efficacy and safety of lobeglitazone versus sitagliptin as an add‐on to metformin in patients with type 2 diabetes with two or more components of metabolic syndrome over 24 weeks.

    Published in:
    Diabetes, Obesity & Metabolism, 2020, v. 22, n. 10, p. 1869, doi. 10.1111/dom.14085
    By:
    • Kim, Sin Gon;
    • Kim, Kyoung Jin;
    • Yoon, Kun Ho;
    • Chun, Sung Wan;
    • Park, Kyong Soo;
    • Choi, Kyung Mook;
    • Lim, Soo;
    • Mok, Ji‐Oh;
    • Lee, Hyoung Woo;
    • Seo, Ji A.;
    • Cha, Bong‐Soo;
    • Kim, Mi Kyung;
    • Shon, Ho Sang;
    • Choi, Dong Seop;
    • Kim, Doo Man
    Publication type:
    Article
    13
    14
    15

    Real-World Analysis of Rapid-Acting Insulin Analog Use and Its Blood Glucose Lowering Effect in Patients with Type 2 Diabetes Mellitus: Results from PASSION Disease Registry in Korea.

    Published in:
    Diabetes, Metabolic Syndrome & Obesity: Targets & Therapy, 2022, v. 15, p. 1495, doi. 10.2147/DMSO.S334944
    By:
    • Kim, Hye Soon;
    • Yu, Jae Myung;
    • Jang, Hak Chul;
    • Choi, Eui Kwang;
    • Park, Jeong Hyun;
    • Shon, Ho Sang;
    • Chung, Choon Hee;
    • Park, Keun-Gyu;
    • Cho, Jae Hyoung;
    • Kim, Won;
    • Lee, Kyoung Hwa;
    • Lee, Jee Hyun;
    • Yoo, Soon Jib
    Publication type:
    Article
    16
    17